Company Directory / Biotechnology
PrivateFor profitBiotechnologyLondon, United Kingdom
Idrx
Idrx is a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment.
- Founded
- 2022 4 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $242M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
4 years old.
Reach
Website ranked #14,817,863 in the world for traffic, about 37 visits a month.
What it does
BiotechnologyLife ScienceOncologyProduct Research
Funding, as listed
$242M currency not stated
- Rounds2
- LatestSeries b, Aug 2024
- Investors9, 5 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Idrx, field by field. Contact details are held but never shown.
The company
- Name
- Idrx
- Type
- For profit
- Status
- Private
- Founded
- 2022
- Founders
- Alexis Borisy, Ben Auspitz, George Demetri, Nick Lydon, Robert Forrester
- Industry
- Biotechnology
- Categories
- Biotechnology, Life Science, Oncology, Product Research
Where
- City
- London
- Country
- United Kingdom
- Markets
- Greater Boston Area, East Coast, New England, Northeastern US
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #14,817,863
- Monthly web visits
- 37
Funding, as listed
- Total
- 242,000,000 (currency not stated)
- Rounds
- 2
- Latest round
- Series b
- Latest round date
- Aug 2024
- Investors
- 9
- Lead investors
- 5
- Listing status
- private
About this record
- Sources
- crunchbase,site-facts
- Last imported
- Sept 2026
Companies like it
Biotechnology in United Kingdom.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 372,993 companies in United Kingdom and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.